Non-Melanoma Skin Cancer Incidence and Impact of Skin Cancer Screening on Incidence  Nora Eisemann, Annika Waldmann, Alan C. Geller, Martin A. Weinstock, Beate Volkmer, Ruediger Greinert, Eckhard W. Breitbart, Alexander Katalinic  Journal of Investigative Dermatology  Volume 134, Issue 1, Pages 43-50 (January 2014) DOI: 10.1038/jid.2013.304 Copyright © 2014 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 1 Trends in age-standardized incidence rates (per 100,000, European standard population) of BCC and SCC by sex. (a) Schleswig-Holstein: during the field trial in 2001, about 200 physicians were trained in an 8-hour training course and 5,425 screening examinations were conducted, leading to an increased awareness among physicians and the population. During SCREEN (2003/2004), a population-based screening with 360,288 participants was conducted (Breitbart et al., 2012). In 2008, a nation-wide biennial skin cancer screening was introduced for persons aged 35 years or older with statutory health insurance. (b) Saarland: in 2008, a nation-wide biennial skin cancer screening was introduced for persons aged 35 years or older with statutory health insurance. BCC, basal cell carcinoma; EASR, age-standardized incidence rates; SCC, squamous cell cancer. Journal of Investigative Dermatology 2014 134, 43-50DOI: (10.1038/jid.2013.304) Copyright © 2014 The Society for Investigative Dermatology, Inc Terms and Conditions